Trelegy Ellipta - Fluticasone with umeclidinium and vilanterol
GSK
Description
Long-acting muscarinic antagonist, Long-acting selective beta2 agonist with corticosteroid.
Adult for moderate COPD: one inhalation once daily – to be taken at the same time each day.
Indications
Maintenance of moderate to severe COPD.
Contraindications
Not to be taken in the case of hepatic impairment or pregnancy.
Preparations Available
Inhalation powder
Sizes Available
Inhalation powder
Trelegy Ellipta 92 mcg/55 mcg/22 mcg/dose, 30 doses
More on: Corticosteroids , Fluticasone (propionate) , Long-acting selective beta2: agonists